Read Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices

Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices

John L Lamattina

4.9/5 (27616 ratings)

Description:High-level commentary on various facets of the pharmaceutical industry from a key leader in the fieldThis book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension.Written by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work Fiscal consequences of curing hepatitis C mRNA vaccines and the race for a cure Why the government does not deserve a piece of Biopharma’s profits Paying for drugs whose ultimate value is unknown The impact of reduced revenues on R&DThis book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices. To get started finding Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices, you are right to find our website which has a comprehensive collection of manuals listed.
Our library is the biggest of these that have literally hundreds of thousands of different products represented.

Pages: 108

Format: PDF, EPUB & Kindle Edition

Publisher: —

Release: —

ISBN: 1119881358

Description: High-level commentary on various facets of the pharmaceutical industry from a key leader in the fieldThis book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension.Written by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work Fiscal consequences of curing hepatitis C mRNA vaccines and the race for a cure Why the government does not deserve a piece of Biopharma’s profits Paying for drugs whose ultimate value is unknown The impact of reduced revenues on R&DThis book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices. To get started finding Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices, you are right to find our website which has a comprehensive collection of manuals listed.
Our library is the biggest of these that have literally hundreds of thousands of different products represented.

Special Offer | $0.00

Special Offer! | $0.00

Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices

Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices

More Books

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image by John L. LaMattina (2013-01-09)

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image by John L. LaMattina (2013-01-09)

Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image? by John L. LaMattina (2013-02-19)

Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image? by John L. LaMattina (2013-02-19)

Drug Truths: Dispelling the Myths About Pharma R & D

Drug Truths: Dispelling the Myths About Pharma R & D

Drug Truths: Dispelling the Myths About Pharma R&D by John L. LaMattina (2008-11-25)

Drug Truths: Dispelling the Myths About Pharma R&D by John L. LaMattina (2008-11-25)

Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image

Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image

Drug Truths & the Dose Makes the Poison

Drug Truths & the Dose Makes the Poison

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image by LaMattina, John L. (2013) Paperback

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image by LaMattina, John L. (2013) Paperback